株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドの遺伝子検査市場の見通し

India Genetic Testing Market Outlook to 2024

発行 GlobalData 商品コード 346062
出版日 ページ情報 英文 26 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.65円で換算しております。
Back to Top
インドの遺伝子検査市場の見通し India Genetic Testing Market Outlook to 2024
出版日: 2017年11月01日 ページ情報: 英文 26 Pages
概要

当レポートでは、インドの遺伝子検査市場について調査分析し、セグメント別の収益実績・予測、カテゴリー別の企業シェア・流通シェア、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 インドの遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 インドの主要企業の概要:遺伝子検査市場

  • 企業概要
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthcare
    • Abbott Laboratories
    • Qiagen N.V.
    • PerkinElmer, Inc.
    • Transgenomic, Inc.
    • Hologic, Inc.

第5章 遺伝子検査市場パイプライン製品

第6章 財務取引情勢

  • パートナーシップ

第7章 最近の発展

  • 決算発表
  • 戦略と事業計画

第8章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC2855DB

GlobalData's new report, India Genetic Testing Market Outlook to 2024, provides key market data on the India Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the India Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Introduction 4

  • 2.1 What Is This Report About? 4
  • 2.2 Genetic Testing Market Segmentation 4
  • 2.3 Definitions of Markets Covered in the Report 5

3 Genetic Testing Market, India 6

  • 3.1 Genetic Testing Market, India, Revenue ($m), 2010-2017 6
  • 3.2 Genetic Testing Market, India, Revenue ($m), 2017-2024 8
  • 3.3 Genetic Testing Market, India, Distribution Share by Revenue ($m), 2017 10
  • 3.4 Genetic Testing Market, India, Company Share by Revenue ($m), 2017 11

4 Overview of Key Companies in India, Genetic Testing Market 13

  • 4.1 Abbott Laboratories 13
    • 4.1.1 Company Overview 13
  • 4.2 PerkinElmer Inc 13
    • 4.2.1 Company Overview 13
  • 4.3 F. Hoffmann-La Roche Ltd 13
    • 4.3.1 Company Overview 13
  • 4.4 Qiagen NV 14
    • 4.4.1 Company Overview 14
  • 4.5 Hologic Inc 14
    • 4.5.1 Company Overview 14

5 Genetic Testing Market Pipeline Products 15

6 Financial Deals Landscape 17

  • 6.1 Partnerships 17
    • 6.1.1 Lucigen Enters into Distribution Agreement with Illumina 17
  • 6.2 Venture Financing 18
    • 6.2.1 iGenetic Diagnostics May Raise USD19.5 Million in Venture Financing 18
    • 6.2.2 SigTuple Raises USD5.8 Million in Series A Financing 19

7 Appendix 20

  • 7.1 Research Methodology 21
    • 7.1.1 Coverage 21
    • 7.1.2 Secondary Research 21
    • 7.1.3 Primary Research 22
    • 7.1.4 Market Modeling and Forecasting 23
    • 7.1.5 Company Share Analysis 24
    • 7.1.6 Distribution Share Analysis 25
    • 7.1.7 Benchmarking 25
  • 7.2 GlobalData Consulting 25
  • 7.3 Contact Us 26
  • 7.4 Disclaimer 26

List of Tables

1.1 List of Tables

  • Table 1: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 7
  • Table 2: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 9
  • Table 3: Genetic Testing Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 10
  • Table 4: Genetic Testing Market, India, Company Share by Revenue ($m), USD Constant, 2017 12
  • Table 5: Genetic Testing Market Pipeline Products 15
  • Table 6: Lucigen Enters into Distribution Agreement with Illumina 17
  • Table 7: iGenetic Diagnostics May Raise USD19.5 Million in Venture Financing 18
  • Table 8: SigTuple Raises USD5.8 Million in Series A Financing 19
  • Table 9: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 23

List of Figures

1.2 List of Figures

  • Figure 1: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 6
  • Figure 2: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 8
  • Figure 3: Genetic Testing Market, India, Company Share (%) 2017 11
Back to Top